February 23, 2021 - AbbVie and Caribou Biosciences, Inc have entered into a collaboration and license agreement for the research and development of chimeric antigen receptory T-cell therapeutics.
Kyle Doherty
Advertisement
Kyle Doherty joined MJH Life Sciences in 2021 and is the lead editor for Oncology Fellows. He also produces print content for OncologyLive, as well as news and conference updates for OncLive.com. Email: [email protected]
Articles by Kyle Doherty
January 29, 2021 - Dana-Farber Cancer Institute has announced the launch of its first-ever venture fund, Binney Street Capital, LLC.
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
FDA Flashback: GI Cancer Decisions and News From July 2026
2
TNFR2 Advances as a Novel Target for Restoring Antitumor Immunity Across Lymphoma and Solid Tumors
3
Early mRNA Vaccine Data Excite Possibilities of Long-Term PDAC Remissions
4
Phase 3 VERSATILE-003 Trial of PDS0101 in HNSCC Is Discontinued
5